Sudden Caffeine Withdrawal Triggers Migraine-A Randomized Controlled Trial
Alstadhaug KB, Ofte HK, Müller KI, Andreou AP
Frontiers in neurology · 18 citas
Cómo se estudió
- Diseño
- Reporte de caso (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2020-09-10 · Front Neurol · vol. 11 · pág. 1002
- Editorial
- Frontiers Media
- Citado
- 36 citas · más que el 86% de estudios similares · 1.9× el promedio de su campo
- Referencias
- 41 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Migraine and Headache Studies · Neuroscience of respiration and sleep · Medicinal Plant Extracts Effects
- Palabras clave
- Caffeine, Migraine, Placebo, Medicine, Crossover study, Pittsburgh Sleep Quality Index, Anesthesia, Randomized controlled trial, Internal medicine, Sleep quality, Pharmacology, Insomnia
4 autores
- Karl Bjørnar Alstadhaug🇳🇴 · autor de correspondenciaNordland Hospital Trust; UiT The Arctic University of Norway
- Hilde Karen Ofte🇳🇴Nordland Hospital Trust
- Kai Ivar Müller🇳🇴University Hospital of North Norway; UiT The Arctic University of Norway
- Anna P. Andreou🇬🇧King's College London; Guy's and St Thomas' NHS Foundation Trust
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objective: Assessing the effects of caffeine withdrawal on migraine. Background: The effects of caffeine withdrawal on migraineurs are at large unknown. Methods: This was a randomized, double-blind, crossover study (NCT03022838), designed to enroll 80 adults with episodic migraine and a daily consumption of 300-800 mg caffeine. Participants substituted their estimated dietary caffeine with either placebo capsules or capsulated caffeine tablets for 5 weeks before switching the comparators for 5 more weeks. Results: The study was terminated due to low recruitment. Ten subjects with a mean age of 46.3 ± 9.9 years, BMI of 24.9 ± 3.7, and a mean blood pressure of 134/83 ± 17/12 mmHg were enrolled. The average consumption of caffeine per day was 539 ± 196.3 mg. The average monthly headache days and migraine attack frequency at baseline was 11.5 ± 4.9 and 5.2 ± 1.2, respectively. At baseline Pittsburgh Sleep Quality Index was 5.8 ± 2.5 and HIT-6 was 62.8 ± 3.9. There were no differences in these or in parameters from actigraphy during the caffeine period compared with the placebo period. One subject withdrew just after entering the study. In the remaining nine, withdrawal triggered severe migraine attacks in seven, causing one more drop-out, and a typical caffeine withdrawal syndrome in two. Caffeine continuation did not trigger migraines, but one attack occurred in the wake of caffeine reintroduction. Conclusions: The study failed to answer how caffeine withdrawal affects migraineurs over time, but showed that abrupt withdrawal of caffeine is a potent trigger for migraine attacks.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.